Skip to main content
Global Bioenergies logo

Global Bioenergies — Investor Relations & Filings

Ticker · ALGBE ISIN · FR0011052257 LEI · 969500H46XRAMTMVB676 PA Manufacturing
Open in API
Filings indexed 443 across all filing types
Latest filing 2017-01-16 Regulatory Filings
Country FR France
Listing PA ALGBE

About Global Bioenergies

https://www.global-bioenergies.com/?lan…

Global Bioenergies develops and commercializes a process to convert renewable resources, such as plant-based sugars and agricultural waste, into isobutene. The company's proprietary technology utilizes fermentation and synthetic biology to produce this key hydrocarbon, which serves as a platform molecule for various applications. The bio-isobutene can be converted into ingredients for the cosmetics industry, specialty chemicals, and renewable fuels. A primary strategic focus is the production of Sustainable Aviation Fuel (SAF) to support the decarbonization of the aviation sector. The process provides a bio-based alternative to petroleum-derived hydrocarbons, aiming to reduce CO2 emissions and dependence on fossil fuels.

Recent filings

Filing Released Lang Actions
GLOBAL BIOENERGIES COMMUNIQUE DE PRESSE
Regulatory Filings Classification · 95% confidence The document is titled "Communiqué de Presse" (Press Release) and announces a strategic partnership between Butagaz and Global Bioenergies regarding the incorporation of bio-isobutene into butane and propane. This type of announcement, detailing a business development, partnership, or strategic move, does not fit the specific financial reporting categories like 10-K, ER, or IR. It is a general corporate announcement. Since it is not a formal regulatory filing (like a 10-K or a specific voting result), nor is it a transcript, presentation, or factsheet, the most appropriate general category for a press release detailing a significant business development is 'Regulatory Filings' (RNS) as a fallback, although 'LTR' (Legal Proceedings Report) or 'TAR' (M&A Activity) are clearly incorrect. Given the options, and recognizing this as a general corporate news release, RNS serves as the best fit among the provided codes for non-standard, non-financial-statement announcements.
2017-01-16 French
GLOBAL BIOENERGIES PRESS RELEASE
Regulatory Filings Classification · 95% confidence The document is explicitly titled and formatted as a "Press release" announcing a commercial partnership between Butagaz and Global Bioenergies regarding the incorporation of bio-isobutene into gas products. This type of announcement, detailing strategic business developments, partnerships, and future plans, does not fit neatly into the specific financial reporting categories (like 10-K, IR, ER, or DIV). It is a general corporate announcement. Since it is not a report itself, nor a specific filing like a Director's Dealing or Capital Change, the most appropriate fallback category is Regulatory Filings (RNS), which serves as a general category for miscellaneous corporate announcements that are not covered by more specific codes.
2017-01-16 English
COMMUNIQUE DE PRESSE
Earnings Release Classification · 98% confidence The document is a press release dated January 3, 2017, announcing the successful completion of the BIOMA+ project phase, the receipt of a final payment (€797k), and providing an update on the company's cash position (€7.4M as of 12/31/2016). It discusses project milestones, future plans (industrial demonstrator, commercial unit), and includes quotes from the CFO and CEO regarding financial visibility and strategy. This content structure—announcing key operational and financial highlights for a specific period (end of year cash) without being a full statutory report (like 10-K or IR)—is characteristic of an Earnings Release (ER). It is not a full transcript (CT), a formal audit report (AR), or a general regulatory filing (RNS) since it fits the ER definition well. FY 2016
2017-01-03 French
PRESS RELEASE
Capital/Financing Update Classification · 95% confidence The document is a press release dated January 3, 2017, announcing the success of the BIOMA+ project, the receipt of a final payment (€797k), and providing an update on the company's cash position as of December 31, 2016. It discusses project milestones, future financing plans (€9 million grant, equity financing), and strategic outlook. This content is characteristic of an initial announcement of financial status or operational progress following a period, but it is not a full quarterly report (IR) or a formal earnings release (ER) which typically contains structured financial tables. It is an announcement detailing financial updates related to project funding and cash position, which aligns best with a general financial update or a specific announcement related to capital/financing activities, or potentially an Earnings Release if it's the primary way they communicate period-end results. Given the focus on project success triggering a payment and the resulting solid cash position, it functions as an early indicator of financial health for the period end. However, since it is a news announcement detailing financial outcomes and future funding, it most closely resembles an Earnings Release (ER) which provides key highlights, or a Capital/Financing Update (CAP) due to the heavy emphasis on grants and funding visibility. Since it explicitly mentions the cash position at 31 December 2016 (period-end), it functions as an Earnings Release highlighting key financial metrics and operational success that led to them. It is too detailed for just an RPA and too specific for a general RNS.
2017-01-03 English
GLOBAL BIOENERGIES COMMUNIQUE DE PRESSE
M&A Activity Classification · 99% confidence The document is a press release dated December 21, 2016, announcing that Global Bioenergies has signed an agreement to acquire the Dutch startup Syngip B.V. It details the terms of the acquisition, including the issuance of new shares and warrants, and mentions that the finalization is subject to shareholder approval at an Extraordinary General Meeting (EGM) scheduled for February 2, 2017. This announcement concerns a significant corporate transaction (merger/acquisition) and the subsequent need for shareholder approval. Since the core subject is the proposed acquisition/takeover, the most fitting category is M&A Activity (TAR). While it mentions a future shareholder meeting, the primary focus is the transaction itself, not the voting results (DVA) or the proxy materials (PSI). It is not a standard financial report (10-K, IR, ER).
2016-12-21 French
GLOBAL BIOENERGIES PRESS RELEASE
Share Issue/Capital Change Classification · 99% confidence The document explicitly announces an agreement to acquire another company (Syngip B.V.) through a share transfer and issuance of new shares and warrants. This activity falls under corporate transactions related to capital structure changes, financing, or M&A. Since the core event is the acquisition/merger proposal, the most fitting category is M&A Activity (TAR). Although it involves issuing new shares (SHA), the primary driver and announcement subject is the takeover/acquisition itself. It is not a standard regulatory filing like 10-K or ER, nor is it a simple announcement of a report (RPA).
2016-12-21 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.